Press Room

A new report released by the American Cancer Society (ACS) last month revealed a shift in the burden of the disease from men to women. Cases of cancer are declining in men while diagnoses are rising in women, specifically younger women. A continued drop in cancer mortality was also noted in the report, thanks in part to advances in early detection and treatment of cancer. The report coincides with the beginning of the 2025 legislative session and the recent introduction of House Bill 433. Supporters of Representative Gina Curry’s legislative proposal include the nonprofit, nonpartisan advocacy affiliate of ACS, the American Cancer Society Cancer Action Network (ACS CAN), and Susan G. Komen For the Cure. One ACS CAN volunteer, a local Pittsburgh breast cancer survivor, is sounding the alarm on the recent report and urging state lawmakers to see House Bill 433 as an opportunity to address the troubling trend.

Activistas de la lucha contra el cáncer se congregaron en el Capitolio de Arizona para instar a los legisladores a que apoyen políticas que amplíen el acceso a una atención médica económica y que prevengan el consumo de tabaco.

BISMARCK, N.D. -- The North Dakota House Business, Industry and Labor Committee on Wednesday gave a “do pass recommendation” on legislation that, if successfully passed, will lead to better outcomes in the fight against breast cancer. 

Governor Josh Shapiro presented his state budget to the legislature yesterday, outlining his vision for the coming fiscal year. In his budget address, Governor Shapiro proposed to maintain funding for key cancer prevention and detection programs and acknowledged health care costs and price transparency as a continued area of interest, which secured high praise from patient advocates concerned over the role cancer plays in limiting Pennsylvanians’ financial mobility. Advocates are hopeful that the budget negotiation process yields progress on additional health care affordability issues, including Pennsylvanians’ access to paid leave, medical debt relief and lifesaving medications.

PIERRE, S.D. – The South Dakota House Commerce and Energy Committee today missed a significant opportunity to make progress against breast cancer, voting to fail legislation on supplemental screenings.
 

PIERRE, S.D. –– American Cancer Society Cancer Action Network (ACS CAN) advocates will arrive at the Statehouse Wednesday for their annual Day at the Capitol.

LAS VEGAS, NEV. – The High Roller Observation Wheel at The Linq Promenade shined teal and white on Friday night in honor of Cervical Cancer Awareness Month, which is observed in January. The American Cancer Society Cancer Action Network (ACS CAN) joined other local advocacy groups and cervical cancer survivors at The Linq Promenade to recognize those who have battled the disease. 

La siguiente es una declaración del Director Senior de Relaciones Gubernamentales de Nueva York de la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN, por sus siglas en inglés), Michael Davoli:

“Tras el discurso sobre la situación del Estado de la Gobernadora Hochul a principios de esta semana, donde en contadas ocasiones se mencionaron el acceso y los costos de la atención médica, los defensores de los pacientes tienen la esperanza de que la gobernadora priorice los bajos costos de la atención médica en su propuesta de presupuesto ejecutivo para el año fiscal 2025-26.

TALLAHASSEE, Florida – Mientras los legisladores de Florida comienzan las reuniones de los comités para la sesión de 2025, la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) les pide que prioricen la reducción del s

As Governor Daniel McKee prepares for his State of the State address, patient advocates are highlighting the results of a new report by the American Cancer Society Cancer Action Network (ACS CAN), which found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.